Cannabis: Legalizing the Leaf - [Business Breakdowns, EP. 42]

At a Glance

Guest Jeff Hoffman, portfolio manager at Marathon Partners Equity Management, focuses on U.S.-listed cannabis companies. This episode dissects the structural transformation of the U.S. cannabis industry from illegal to legal and the investment opportunities it presents. Jeff Hoffman's core thesis is that the U.S. cannabis industry (MSOs) is one of the most structurally inefficient markets today, and this inefficiency—driven by high capital costs, low institutional ownership, and depressed valuations due to federal illegality—is precisely the source of multi-fold future returns.

Regulatory Shackles and Structural Inefficiency: The Unique Dilemma and Opportunity of MSOs

Jeff Hoffman argues that the core conflict in the U.S. cannabis industry lies between federal and state laws, creating a uniquely and extremely inefficient competitive landscape for Multi-State Operators (MSOs).

• History and Current State: Cannabis has been classified as a Schedule I drug (alongside heroin) since 1970, yet 37 states have now legalized medical use, and 18 states have legalized adult use. The total market size is approximately $100 billion, with the legal market accounting for only $25 billion and the illicit market for $75 billion. Jeff Hoffman notes that the core growth logic for the industry is not creating new demand but "moving consumers from the illicit market to the legal market."
• Mechanism Breakdown: Each state is an independent market, and products cannot be transported across state lines. This forces MSOs to rebuild expensive cultivation and retail infrastructure in every state where they hold a license (construction costs of $400-$500 per square foot). More critically, federal illegality leads to:

1. Inability to List on Major Exchanges: MSOs can only trade on the Canadian Securities Exchange (CSE), resulting in extremely poor liquidity. The top five MSOs have a combined market cap of $20 billion but an average daily trading volume of only $6 billion; in contrast, a Canadian LP like Canopy Growth, with a market cap of just $4.5 billion, has an average daily trading volume of $70 million.

2. Exclusion of Institutional Investors: Due to custody and compliance issues, only about 4% of MSO shares are held by institutions. Jeff Hoffman compares this to "Bitcoin a few years ago," offering retail and nimble capital a chance to "get ahead of large institutions."

3. Extremely High Tax Burden and Cost of Capital: Because of federal illegality, MSOs cannot deduct most operating expenses like normal businesses, resulting in effective tax rates of 50%-70%. Meanwhile, debt costs are as high as 8%-10%, and for smaller operators, debt costs can exceed 20%.

• Data Chain: Despite these significant hurdles, the financial data for MSOs is remarkably strong. Leading MSOs boast gross margins exceeding 50% and EBITDA margins exceeding 30%. Jeff Hoffman points out that MSOs currently trade at an average of 8x expected 2022 EBITDA, but based on expected 2024 EBITDA, the valuation is only 4-5x. He estimates that if the legal market reaches $750-$100 billion over the next decade, with a 30% EBITDA margin and a 20x CPG-type valuation, the entire sector's market cap could grow from its current $30 billion to $450-$600 billion.

Catalysts and Competition: From a "Cash Business" to a "National Brand"

Jeff Hoffman believes that gradual regulatory reform, particularly the SAFE Banking Act, is the core catalyst to unlock valuations, and that MSOs' real competition is the illicit market, not each other.

• Core Catalyst: The SAFE Banking Act aims to protect financial institutions that serve legal cannabis businesses. The bill has passed the House of Representatives five times and has 180 bipartisan co-sponsors. Jeff Hoffman judges the likelihood of its passage to be high. Once passed, it would allow MSOs to list on higher-liquidity exchanges (like the Toronto Stock Exchange) and resolve custody issues, thereby attracting hundreds of billions of dollars in new capital into this narrow, illiquid market.
• Competitive Landscape: In states with limited licenses (e.g., only 10 in New York, 2 in Minnesota), license scarcity creates a significant moat. Jeff Hoffman emphasizes that MSOs should not engage in price wars with each other because "the competition is not another MSO; the competition is the illicit market." By creating differentiated, innovative products, the legal market can continuously capture market share from the illicit market.
• Business Model: Vertical integration (growing your own + retailing your own) is the most ideal model for MSOs. Using New Jersey as an example, cultivation costs are about $700/lb, wholesale prices are $2,500/lb, and retail prices can reach $5,000/lb. A vertically integrated MSO captures the profits from the entire value chain. In contrast, Canadian producers must sell their products to provincial agencies, cutting them off from most of the profit.

Consumption Trends and Future Outlook: From "Joint" to "Consumer Product"

Jeff Hoffman argues that the consumption form of cannabis is shifting from medical-use "smoking" to mature-market "consumer products," which will significantly broaden the consumer base.

• Form Evolution: In the medical market, the primary consumption form is smoking (flower). In mature markets, flower and pre-rolls account for about 50%, vaporizers for 30%, and edibles for 10%. Jeff Hoffman predicts that as more older consumers enter the market, they will prefer non-inhalable products like edibles and seltzers. He shared a story of a 75-year-old who, after trying a recommended edible, immediately gave up smoking.
• Competition with Alcohol: Cannabis is eroding alcohol's market share. The U.S. alcohol market is $250 billion, while the cannabis market is $100 billion. A survey shows that among people who consume both cannabis and alcohol, 44% prefer cannabis, while only 30% prefer alcohol. The average annual spending of a cannabis consumer ($2,700) is nearly double that of an alcohol consumer ($1,400), with no hangover or calorie burden.
• Future Projection: Jeff Hoffman believes that when large eastern states like New York and New Jersey open adult-use sales, it will fundamentally change society's negative stereotypes about cannabis. He predicts that over the next decade, leading MSOs will be acquired by large consumer packaged goods companies (like Altria, Anheuser-Busch InBev), but currently, due to federal illegality, these strategic buyers can only make "option-like" acquisitions through Canadian LPs. Simultaneously, MSOs themselves are acquiring smaller operators at low valuations of 3-4x EBITDA, creating a unique consolidation opportunity.

Position Moves

Position	Guest Stance	Key Data
Curaleaf	Not Explicit	Mentioned as a leading MSO with retail and vertically integrated operations.
Green Thumb Industries	Not Explicit	Mentioned as a leading MSO.
Trulieve Cannabis	Not Explicit	Mentioned as a leading MSO.
Verano Holdings	Not Explicit	Mentioned as a leading MSO.
Canopy Growth	Risk Warning	Market cap of $4.5 billion, average daily trading volume of $70 million. Jeff Hoffman believes it is "completely unrelated to U.S. cannabis" and overvalued.
Tilray	Risk Warning	Mentioned as a Canadian LP. Jeff Hoffman believes it is unrelated to the U.S. cannabis market.

Key Takeaways

1. "The competition is not another MSO; the competition is the illicit market." (Jeff Hoffman) — The core task for the legal market is to create differentiated products to attract consumers away from the illicit market, not to engage in price wars with peers.

2. "The U.S. cannabis market is 12 times larger than the Canadian market, but its market cap is only 2.5-3 times." (Jeff Hoffman) — This is the structural valuation discount caused by federal illegality and a potential source of future returns.

3. "Leading MSOs trade at 4-5x expected 2024 EBITDA, while they are growing at 40-50%." (Jeff Hoffman) — This mismatch between growth and valuation is the core argument for Jeff Hoffman's belief in a "generational wealth creation opportunity" in this sector.

4. "Only about 4% of MSO shares are held by institutions." (Jeff Hoffman) — Extremely low institutional ownership means that once regulatory hurdles are removed, a massive wave of buying power will enter, driving a valuation re-rating.

5. "The SAFE Banking Act has passed the House five times and has 180 bipartisan co-sponsors." (Jeff Hoffman) — He sees this as the most likely regulatory catalyst to pass first, addressing the industry's cash risk and cost of capital issues.

6. "The average annual spending of a cannabis consumer ($2,700) is nearly double that of an alcohol consumer ($1,400)." (Jeff Hoffman) — This indicates very high user stickiness and consumption intensity for cannabis as a consumer product.

7. "In states with limited licenses, a vertically integrated MSO can achieve a final retail price of $5,000 on a cost of $700." (Jeff Hoffman) — This reveals the astonishing profit potential from license scarcity and the vertical integration model.

8. "MSOs are acquiring smaller operators at 3-4x EBITDA. I don't know of any other industry where you can acquire such high-growth companies at these multiples." (Jeff Hoffman) — This points to a unique arbitrage opportunity within industry consolidation.